FDA Approves New Second-Line Oral Treatment For ALK+ Lung Cancer The U.S. Food and Drug Administration has approved the oral medication Alunbrig for the treatment of ALK+ non-small cell lung cancer. Find out more about the newly approved drug treatment. by Luan Chan
Health Lung Cancer Treatment: Keytruda Better Than Chemotherapy In Patients With Non-Small Cell Lung Cancer by Rhodi Lee
Health Whole Brain Radiotherapy Not Beneficial To Patients Whose Lung Cancer Has Spread To Brain by Rhodi Lee
Healthy Living/Wellness FDA Okays Pfizer's Lung Cancer Drug Xalkori For Expanded Use by Alyssa Navarro
Healthy Living/Wellness Can Coke Improve Effectiveness Of Lung Cancer Drug Tarceva? by Rina Marie Doctor
Healthy Living/Wellness Immunotherapy Drug Keytruda More Effective Than Chemotheraphy For Advanced Lung Cancer by Rina Marie Doctor
Healthy Living/Wellness New Lung Cancer Pill By AstraZeneca Wins Early FDA Approval by Charity Johnson
Healthy Living/Wellness Merck's Star Drug Keytruda Improves Overall Survival Of Lung Cancer Patients by Angela Laguipo
Healthy Living/Wellness New Drug Atezolizumab Shrinks Lung And Bladder Cancer Tumor Claims Roche by Rhodi Lee
Healthy Living/Wellness Avastin Copycat ABP 215 Shows Positive Results In Lung Cancer Study by Katherine Derla
Healthy Living/Wellness Cutting Edge Cancer Developments That May Boost Humanity's Fight Against Cancer by Ted Ranosa